JAK2 and acute myeloid leukemia: Pracinostat, also named SB939, is a pan-HDAC inhibitor that showed synergism with JAK2 inhibitors in AML models and increased sensitivity to BCR-ABL kinase inhibitors in CML.659,660 Several clinical trials have investigated its efficacy in MDS and MF.